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Accessory molecules expressed on T cells can mediate adhesion between T 
cells and other cells, or the extracellular matrix. The same T-cell accessory 
molecules participate in a dialogue with their ligands (counter-receptors) 
on the antigen-presenting cells, and elicit signals that determine the 
specifics of activation and subsequent differentiation of the T cells and 
antigen-presenting cells. 
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Introduction 
The T-cell receptor (TCR&CD3 complex is critical to 
T-cell recognition because it confers antigen-specificity 
and initiates a cascade of biochemical events that are es- 
sential to T-cell activation (see [l] for a review). Binding 
and aggregation of TCR-CD3 by MHC and antigenic pep- 
tide or by CD3 monoclonal antibody (mAb) is, in most 
model systems, insufficient to activate resting T cells, and 
may even induce tolerance (see [2] for a review). Multi- 
ple T-cell surface molecules have been demonstrated to 
be capable of co-stimulation that is sufficient to fully ac- 
tivate T cells, in combination with a TCR--CD3-mediated 
signal. Epically, this co-stimulation is demonstrated us- 
ing experimental systems in which the presence of mAbs 
specific for these molecules facilitates activation of T cells 
by anti-TCR-CD3 mAbs or by specific antigen. 
Since Clark reviewed data on four such molecules in 1986 
[3], the number of co-stimulatory or accessory molecules 
has mushroomed to more than 20 (for a review see [4] >. 
The excitement regarding n&b-mediated co-stimulation 
results from the presumption (which we share) that the 
mAbs often mimic the natural &and (delined here as 
the molecule expressed on an apposing cell that inter- 
acts with the T-cell accessory molecule). The next step 
is obligatory, and is the definition of the relevant ligands 
and analysis of their capacity to mediate co-stimulation 
(the best dehed are summarized in Fig. 1). I&and char- 
acterization has been achieved for three receptor-l&and 
pathways that participate in T-cell antigen-presenting cell 
@PC) interaction: CD2-lymphocyte fimction-associated 
antigen (LFA)3, LFA-l-intercellular adhesion molecule 
(IcAM)-1 and CD28-B7. We will review the progress that 
has been made in understanding these pathways. Com- 
ment is also made on parallels between these pathways 
and recently-defined adhesion pathways that mediate 
T-cell interaction with extracellular matrix (ECM): very 
late antigen (VIAPi-fibronectin (FN), VLA-5-FN, VLA- 
G-laminin (LN), VI.A+coUagen, CD26-collagen) (see 
Fig. 1). 
Superl?cially, there appears to be a great redundancy of 
molecules involved in co-stimulation. On reflection, how- 
ever, it becomes apparent that T-cell interactions with 
APCs are complex multistep processes that critically de- 
pend on both adhesion and signal transduction. As an 
illustration of this complex dialogue, we will also review 
in detail, the interaction of T cells with two kinds of APC, 
monocytes and B cells, with a particular emphasis on 
the roles of the T-cell molecules CD2, LFA-1 and CD28 
in each case, we find that multiple signals are integrated 
by the participating cells and are used to program the 
differentiation events that result from the T-cell-APC en- 
counter, 
Interplay between adhesion and activation 
Many adhesion molecules are involved in T-cell 
co-stimulation 
Adhesion molecules are ideally situated to transduce in- 
formation to the cell during the adhesion event i.e. to in- 
form the cell that contact has been made and to convey 
information regarding the character of the apposing cell. 
This realization, obvious only in retrospect, emerges from 
the finding that many adhesion molecules also mediate 
co-stimulation. Thus adhesion molecules are not simply 
‘glue’, but rather transducers of information. 
CD2 was the first T-cell molecule for which dual roles 
in adhesion and activation were clearly established (for 
review see [5]). Recent studies have relined these con- 
cepts. Because of the dramatic capacity of CD2 to ac- 
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CD3-TCR MHC-AG 
T cell Apposing cell 
tivate cells, the importance of its adhesive role is of- 
ten under emphasized. However, recent studies suggest 
that CD2-LFA-3 adhesion mediates substantial augmen- 
tation of antigen-specific T-cell responses [6*]: speciii- 
tally, augmentation is observed following transfection of 
T cells with recombinant CD2 cDNA lacking the cytoplas 
mic domain responsible for the signalling capacity of the 
molecule. There is controversy over whether the func- 
tional synergism between CD2 and CD3 is partly a result 
of a physical association between the molecules: whereas 
one study provided evidence of physical association be- 
tween CD2 and CD3 by co-precipitation analysis [7*], an- 
other failed to see co-clustering of CD3 with CD2 in the 
area of cell-cell interaction, during the antigen-indepen- 
dent phase of conjugation [@I. 
In contrast to CD2, LFA-1 historically has been recog- 
nized principally as an adhesion molecule (for review 
see [9] >. LFA-1 mediates binding not only to activation- 
inducible ligand RAM-1 but also to an additional ligand 
ICAM- [lo*], which is constitutively expressed on en- 
dothelial cells. Recent studies with ICAM- tmnsfectants 
[ 11*,12*] or with purikd ICAM- [ 13*,14*] indicate that 
the LFA-I-ICAMl pathway is also involved in co-stimu- 
lation of TCR-CD3mediated T-cell activation. Although 
the mechanism of co-stimulation remains unclear, evi- 
dence for signalling through LFA-1 comes from studies in 
which crosslinking of T cell LFA-1 with n-&s was found 
to induce increased intracellular Ca2+ [Ca2+ ]I concen- 
trations [ I5*,16*]. 
The CD28 molecule was initially identiiied as a potent co- 
stimulator of T-cell activation (for a review see [ 171). Re- 
Fig. 1. Accessory molecules implicated 
in adhesion and co-stimulation of rest- 
ing T-cells. *LFA-liCAM-2 and VLA- 
4/VCAM-1 have only been shown to 
play a role in adhesion. Ag. anti- 
gen; ECM, extracellular matrix; ICAM, 
intercellular adhesion molecule; LFA, 
lymphocyte function-associated anti- 
gen; MHC, major histocompatibility 
complex; VLA, very late antigen. 
cently, the CD28 ligand was identikl as the previously 
defined B-cell activation antigen B7 (or BB-1) [ 18**]. A 
dual role for the CD28B7 pathway in adhesion and co- 
stimulation has been demonstrated by the demonstra- 
tion that immobilized purified B7 protein mediates T-cell 
adhesion and co-stimulation that results in T-cell pro- 
liferation and cytokine production [ 19*]. Studies of co- 
stimulation by mAb-ligation of CD28 have identified sev 
eral mechanisms by which CD28 influence T-cell acti- 
vation. Firstly, aggregation of CD28 appears to activate 
a phospholipase C that is functionally different from 
that activatted by TCR-CD3 [20*]. Secondly, there is a 
unique transcriptional regulatory sequence in the inter- 
leukin (IL)-2 gene that is involved in CD28-induced acti- 
vation [21*], and thirdly, CD28 co-stimulation partly acts 
by stabilization of cytokine mRNA (e.g. IL-21 [22*]. 
The concept of co-stimulation has been expanded by 
studies of ligands that are neither cytokines nor cell-sur- 
face molecules, but are ECM proteins. Co-stimulation by 
five such receptor-ECM interactions has been described. 
Four of the T-cell adhesion receptors for these ligands 
are members of the VA or j!ll (CD291 subfamily of inte- 
grins (for a review see [23]). The details are complex 
because some of these receptors have more than one 
l&and, and one ligand may have various receptors. For 
example, T-cell MA-4 and VLA-5 bind to distinct sites 
on the ECM protein, FN [24.,25*]. The two other T- 
cell in&grin-mediated interactions implicated in co-stim- 
ulation are VU-3 binding to collagen [26*] and ~~4-6 
binding to LN [25*]. Collagen also mediates co-stimula 
tion via the CD26 molecule (or Tp103, DPPIV) [26*], 
2% Lvmuhocvte activation and effector functions 
which is not a member of the in&grin family but is a 
dipeptidylpeptidase. All these receptor-l&and combina- 
tions co-stimulate in CD3 mAb-mediated T-cell activation 
[26*-30*]. 
The biological relevance of co-stimulation by ECM 
molecules remains to be defined. One interesting possi- 
bility is that the ECM environment that surrounds a T cell 
migrating through tissue, influences its ability to be acti- 
vated, or its subsequent differentiation (see below). The 
strong parallels between T-cell interaction with ECM and 
with other cells is emphasized by the finding that VLA-4 
is not only an FN receptor but also binds the cell-sur- 
face molecule VCAM-1 [31*]. The mode by which these 
ECM receptors co-stimulate is largely unknown although 
it has recently been shown that VLA5-media&l co-stim- 
ulation by FN induces the IL2 gene transcription factor 
AP-1 [32*]. 
Adhesion is acutely regulated by activation 
T-cell adhesion is closely interconnected with T-cell ac- 
tivation. Not only does adhesion inlluence T-cell stim- 
ulation as mentioned above, but the activation state of 
the T cell also affects adhesion. The first detailed de- 
scription of this active interplay between TCR-CD3-me- 
diated activation and adhesion was given by Dustin and 
Springer [33**] for LFA-1 binding to ICAM-1. Subse- 
quently TCR-CD3-mediated activation was also found 
to affect binding via the related integrins VIA-4, VIA5 
and VLA-6 [25*], and a fifth molecule with a different 
structure, the CD8 glycoprotein [3&l. This contrasts 
with CD2-mediated adhesion, which appears to be ln- 
dependent of acute activation [35*]. For each of the 
four integrlns, TCR-CD3 crosslinking results in a rapid 
( < 10 mln) increase in avid&y of adhesion without an 
increase in cell-surface expression of the particular re- 
ceptors; furthermore, the augmentation of adhesion is 
transient. Although these results were obtained in arti- 
ficial systems, they make a great deal of sense in their 
prediction that antigen-specllic T-cell recognition results 
in augmented adhesion that stabilizes the T-cell interac- 
tions with apposing cells (or ECM) for a perlod of time. 
The molecular mechanism(s) that accounts for these 
changes is not understood and may be regulated in part, 
by signals from the T-cell receptor via protein klnase C 
(PKC) because they are inhibited by the PKC inhibitor 
staurosporine ( [33**], and Y Shin&u unpublished data). 
Among many possibilities, two are particularly attractive 
explanations for the regulation of avidity. One is that in- 
tracellular events a&cting the integrin molecule (such as 
phosphotylation) induce conformational changes of the 
ligand-binding domain that alter its alllnity for ligand. The 
other is that intracellular events result in micro-cluster- 
ing (either by self association or by cytoskeletal linkage), 
which augments local avidity [36]. 
Activation via CD2 alone also appears to affect integrin- 
mediated adhesion. Stimulating pairs of CD2 mAbs re- 
sults in a rapid, increased avidity of LFA-1 and VLA in- 
tegrins for their respective ligands [25’,37’]. Although 
the induced binding of T cells by TCR-CD3 [33**,38] 
is quite transient (x 30-40 min), adhesion mediated via 
CD2 stimulation is longer in duration ( [37*], and Y 
Shimizu, unpublished data). 
T-cell adhesion to APCs constitutes a bilateral process be- 
cause generally? APCs also express adhesion molecules. 
Thus, it is not surprising to find that for the APC, like the 
T cell, activation events may alter the avidity of adhesion 
molecules. For example, analogous to TCR--CD3-medi- 
ated stimulation of T cells, crosslinking of HIA class II 
antigens on monOcytes induces high avidity LFA-1 func- 
tion [39]. 
Adhesion is regulated by differentiation 
Adhesion is influenced not only by immediate stimulation 
of the T cell, but also by the d.i@erentiation state of the 
T cell and the apposing cell. Human memory T cells ex- 
press significantly higher levels of an array of adhesion re- 
ceptors and ligands, including LFA-1, ICAM-1, CD2, LFA-3 
[401, CD26 [41*] X4-4, VU-5 and VLA-6 [25’] than do 
naive cells. Such regulation of expression by T-cell differ- 
entiation suggests that their function is critical to the dif- 
ferentiated function of those cells. In vitro studies [38] 
show that upon acute activation via TCR-CD3 or CD2- 
memory cells bind more than naive cells to purilied llg- 
ands. In v&o, Mackay et al. [42*] have demonstrated that 
naive cells recirculate preferentially through lymph nodes 
whereas memory cells recirculate primarRy through non- 
lymphoid tissue. This suggests that homing and migration 
patterns of T cells depend on the dlfferentlation state of 
the cell. 
The ligands for T-cell adhesion molecules are also dra- 
matically regulated. Activation results in induction of B7 
on B cells and ICAM- on monocytes, which is critical 
to their interaction with T cells (see below). The most 
complete and elegant studies of regulated expression of 
ligands have been carried out on endothelial cells. T 
cells bind to endothelium via molecular pathways that in- 
clude: LFA-l-ICAM-1; LFA-l-ICAM-2; and VIA-4-VCAM-1. 
A fourth adhesion pathway exists for a memory subset 
of CD4+ T cells and is mediated by the activation-in- 
duced ligand, endothellal leukocyte adhesion molecule 
(EL&I)-1 on endothellal cells [43*-45*]. The receptor 
on T cells, however, has not yet been defined. ICAM- is 
expressed on resting endothellum and its transcription 
is not augmented with intlammatoty cytokines [10*,46]. 
In contrast, resting endothelium cells express ICAM- 
mi&naUy, and do not express VCAM-1 or EIAM-1 at all 
[43’,46,47*]. All three molecules are rapidly induced by 
IL-# or tumor necrosis factor (TNF). Interferon, how 
ever, selectively induces ICAM-1, and IL-4 only increases 
VCAM-1 ([48*], and W Newman, personal communica- 
tion) and downregulates ICAM-l-expression 148.1. Thus, 
T-cell capture by endothelium, the critical lirst step in T- 
cell migration into tissue, may be exquisitely regulated by 
the molecules expressed by endothelial cells. 
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A dialogue between T cells and APCS 
h ~~gen-sp&fic interaction of a T cell with an APC 
can be regarded as a highly specific sequence of events, 
tich shows much resemblance to some of nature’s 
complex ‘mating rituals. Specific interaction between a 
T cell and an APC involves a bilateral exchange of sig- 
nals, which triggers a biochemical cascade of events that 
lead to specific activation and differentiation not only of 
the T cell, but also of the apposing APC. Similarly, T-B- 
cell interactions may lead to activation and differentiation 
of B cells. Incomplete exchange of information may lead 
to a failure of complete activation, and may even induce 
the T cell to become anergic/tolerized to the improperly 
presented antigen. 
T cell-monocyte interaction 
zany antigen-specific T-cell activation models use mono- 
cytes as APCs. Figure 2 collects information from various 
systems into a proposed sequence of signal exchanges 
that ultimately lead to T-cell proliferation and monocyte 
cytokine secretion by the monocyte. initial, weak cell con 
tact (Fig 2a) occurs between a T cell and monocyte; this 
initial contact may be mediated by LFA-1 (which has a 
low but detectable affinity for ICAM-1 on resting T cells) 
or by other receptor-l&and interactions. TCR-CD3 en- 
gagement by MHCantigen (Fig. 2b) results in signal de- 
livery in both the T cell and the monocyte. In the T 
cell, TCR-CD3 stimulation results in the induction of 
high avidity IFA- [33**], which considerably strength- 
ens the T cell-monocyte interaction. Similarly, crosslink- 
ing of MHC-antigen on the monocyte induces high avid- 
ity LFA-1 on the monocyte [39’]. This strengthened LFA- 
l-dependent interaction may allow weaker adhesive in- 
teractions, such as CD2-LFA-3, to occur. 
The ability of purified CD2 to induce IL-1 secretion from 
monocytes [49”] suggests that such interactions may be 
critically important in the induction of IL-1 mRNA Ad- 
ditional or alternative mechanisms for initial IL-1 mRNA 
production may also exist, as Landis et al. [50*] have 
reported that a cell contact-mediated signal provided by 
CD3 mAb-stimulated T cells (but not resting T cells) is 
important for the initial phase of IL-1 mRNA induction. 
This cell contact-mediated signal does not require new 
protein synthesis [ 50.1. Further activation of the mono- 
cyte leads to important cell-surface changes on the mono- 
cyte and ultimately to cytokine secretion (Fig. 2~). Such 
activation may be mediated by cell contact-mediated sig- 
nals of the T cell, and by soluble factors produced by the 
activated T cell [50*1 or other cells in the microenviron- 
ment. 
Kaw&ami et al. [51**] have demonstrated in a monocyte- 
dependent model system that optimal T-cell activation re- 
quires crosslinking of the TCR-CD3 complex, the pres- 
ence of the cytokines IL-lb and IL-~, and and IFN-y-in- 
duced membrane-bound co-stimulatoty signal expressed 
on monocytes. Studies of the molecules involved in this 
co-stimulation demonstrate a requirement for both the 
LFA-l-ICAM- and CD2-LFA-3 pathways, and increased 
ICAM- expression on the activated monocytes (GA van 
Seventer et al. unpublished data). This model system de- 
scribed by Kawakami et al. [51**] shows much resem- 
blance to the in vitro models for induction of clonal an- 
ergy in murine T helper (Th)l-type clones, In both, a 
cell contact-mediated signal, which cannot be replaced 
by the addition of various cytokines is required in addi- 
tion to MHC and antigenic peptide, to elicit optimal T-cell 
stimulation, (see [2] for review). The exact nature of the 
membrane-bound co-stimulatoty signals in both systems 
is not well resolved. In our proposed model (Fig. 2) the 
expression of the membrane-bound co-stimulatory sig- 
nal by the monocyte, along with induced secretion of cy- 
tokines such as IL-1 fl and IL-~ by the activated monocyte, 
finally leads to IL-a-dependent proliferation and differen- 
tiation of the T cell (Fig. 2d). 
T-cell-R-cell interaction 
A similar dialogue occurs in T-B-cell interaction, al- 
though some of the molecules involved are different (see 
Fig. 3). Even though we have attempted to simplify the se- 
quence of events for clarity, the T-B-cell interaction cur- 
rently involves at least 14 different surface molecules on 
the two apposing cells! As with monocytes, weak adhe- 
sion (Fig. 3a) is followed by antigen-specific interaction 
of TCR-CD3 with antigen-MHC, and the delivery of sig- 
nals to both the T cell and B cell (Fig. 3b). Direct evi- 
dence for a role of the CD2-LFA-3 pathway (Fig 3b) is 
not yet established. Although not directly demonstrated, 
triggering of the antigen-MHC complex on the B cell may 
increase the adhesion of the B cell to the T cell; in ad- 
dition, recent studies indicate that crosslinking of class 
II antigens on B cells results in the induced expression 
of the CD28 ligand B7/BB-1 [52*], which is likely to be 
critical in the later steps of this interaction (see below). 
On the T cell, TCR-CD3 activation results in high avidity 
LFA-1 function and increased T-cell adhesiveness [33**]. 
Studies of B-cell activation also suggest that a signal pro- 
vided by CD3 mAb-activated T cells (but not resting T 
cells) is necessary for B-cell entry into the Gl phase of 
the cell cycle. This signal apparently requires synthesis of 
a new protein (Protein X in Fig. 3) [53**,54**,55*,5&]. 
Thus, (Fig. 3c), denotes the delivery of a signal to the 
partially activated B cell by Protein X. Step (Fig 3d) in 
volves B-cell co-stimulation of the T cell and is proposed 
as a result of evidence that activated, but not resting 
B cells are effective accessory cells for T-cell activation 
[ 571. Recent studies in murine models of in vitro induc- 
tion of clonal anergy suggest that resting B cells lack the 
capability of highly enriched, activated B cells to pro- 
vide the membrane-bound co-stimulatoty signal neces- 
sary to prevent induction of clonal anergy i58.1. The 
nature of any membrane-bound co-stimulatoty signal(s) 
on activated B cells remains largely undefined. Recently 
however, two studies have demonstrated that mAbs spe- 
cific for CD28 or B7 inhibit allo-activation of CD4+ 
T cells by B lymphoblasts [ 52*,59*], which makes B7/‘BB- 
1 a plausible candidate for such a membrane-bound co- 
298 lymphocyte activation and effector functions 
(a) Resting Resting 
Partial activation 
(Tl) increased LFA-1 
avidity 
Partial activation 
(Ml) Increased LFA-1 
avidity 










Fis 2 T cell-monocyte bilateral interaction. Schematic depic- 
tion of the multiple pathways involved in T-celCmonocyte in- 
teraction (see accompanying text on T-cell-monocyte interac- 
tion for further details). Ag, antigen; ICAM, intercellular adhe- 
sion molecule; IL, interleukin; LFA, lymphocyte function-associ- 
ated antigen; MHC, major histocompatibility complex; TCR, T-cell 
receptor. 
stimulatoty molecule on B cells. Not surprisingly, the LFA- 
l-ICAM- [60*] and CD2-LEA-3 [61] pathways have also 
been implicated in this co-stimulation, and additional cy 
tokines produced by activated B cells may further facili- 
tate activation of the T cell. 
Finally, B-cell co-stimulation of the T cell results in pro- 
liferation and dilfetentiation of the T cell. Initially T-cell 
secretion of IL-4 drives the B cell into the S phase of 
the cell cycle (Fig. 3e) [ 53**,54**,55*,56*]. Subsequently, 
the T cell produces IL-5, which induces IgM produc- 
tion and further isotype switching (Fig 3f) [55*,560]. 
T-cell-induced differentiation of B cells is also shown to 
be dependent on the LFA-l-ICAM- [@I, CD2-LFA-3 
[61] and CD28B7 [5$P] pathways. It is unclear, how- 
ever, whether this solely reflects a role for these path- 
ways in co-stimulation of T cells, leading to production 
of cytokines such as IL-4 and IL-5 by the T cell, or a 
more direct involvement of these pathways with differ- 
entiation of B cells. Thus this complex bidirectional in- 
terplay leads to proliferation and differentiation of both 
interacting cells. 
Integration of multiple signals influences 
differentiation and effector function of T cells 
It is an appealing concept that the multiplicity of molec 
ular Interactions between T cell and APC detetmine the 
specifics of activation, and subsequent differentiation of 
the T cell and APC. Support for this concept comes from 
evidence that various co-combinations of stimuli gener- 
ated by dilferent accessory molecules induce tierent re 
sponses from T cells and different T-cell subsets respond 
diIferently to stimulation via accessory molecules. The 
former is of particular relevance to the present discus- 
sion Such regulation of alternative T-cell effector func- 
tions by co-stimulatory molecules is Illustrated by a re- 
cent study that describes IL-la production by T cells. 
Iate ( > 48 h) IL-la secretion is achieved by stimulation 
through combinations of CD2 and CD28 mAbs (or CD3 
and CD28 mAbs), but not by any of these mAbs in iso- 
lation, although they are able to induce T-cell prolifer- 
ation and TNF-a secretion [62*]. One can also envision 
that co-stimulatoty molecules may regulate different effec- 
tor functions. For example, Eljaafari et al [63’] demon- 
strated that two distinct pairs of CD2 rnAbs (which pos- 
sibly mimick different ligands), each of which induce dif 
ferent second messengers, stimulated bifunctional CD4+ 
T-cell clones to perform either helper or cytolytic func- 
tions. These data support the hypothesis that the combi- 
nation of accessory-cell ligands expressed by an apposing 
APC will strongly shape the subsequent T-cell differenti- 
ation: ECM ligands in the vicinity may also contribute. 
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(84) Differentiatior Fig. 3. T cells cell bilateral interac- 
tion. Schematic depiction of the mul- 
tiple pathways involved in T cell-B 
cell interaction (see accompanying text 
on T cell-B cell interaction for further 
details). Ag, antigen; ICAM, intercellu- 
lar adhesion molecule; LFA, lympho- 
cyte function-associated antigen; IL, in- 
terieukin; MHC, major histocompatibil- 
ity complex; TCR, T-cell receptor. 
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Conclusion 
Given the interest and progress in accessoty molecules, 
this review has barely scratched the surface. It has dealt 
with selected studies that illustrate the following themes, 
which we view as important in a general understanding 
of accessory molecules in T-cell activation. Firstly, there 
is a multiplicity of molecules involved in T-cell activation. 
Secondly, there is a dynamic interplay between adhesion 
and activation wherein adhesion molecules mediate sig- 
nal transduction and intracellular signals modulate the 
character of the adhesion. Thirdly, cell-cell interactions 
such as T cell with APC involve a multistep dialogue be 
tween receptors on the T cell and their ligands on the 
APC. Finally multiple signals from these diverse molecu- 
lar interactions are integrated by poorly defkd molecu- 
lar processes within the cells, which then determine the 
specifks of activation and subsequent diiferentiation of 
the T cell and APC. 
7. BROWN MH, cANII(Eu. DA, BRA~AND G, CRUMPTON MJ, 
. GUUBERG M: The CD2 Antigen Associates with the T-cell 
Antigen Receptor CD3 Ant&n Complex on the Su&ce of 
Human T Lymphocytes. N&we 1989, 339551-553. 
Reports rhat 40% of the cell-surface CD2 molecules can be speciIicaUy 
co-pricipitated in association with the TCR-CD3 complex, when using 
a digitonin-based solubiiization method. 
8. KOY~ S, L~WTON T, NOV~CK D, RECNY MA, SUXXNO RF, 
. WAUNER BP, REINHERZ EL Role of Interaction of CD2 
Molecules with Lymphocyte Function-associated Antigen 3 
in T-cell Recognition of Nominsi Antigen. Pnx Nut1 Acud 
Sci USA 1990, 87:2603-2607. 
During conjugate formation, CD2 but not CD3 molecules are redis- 
tributed into the region of ceUceU interaction in an antigen-inde- 
pendent way, suggesting that physical association of CD2 with CD3 
molecules is not essential for T-cell activation. 
9. SPRINGER TA: Adhesion Receptors of the Immune System. 
Nature 1990, 346:425-434. 
Acknowledgements 
10. STAUNTON DE, DUSTIN ML, SPRINGER TA: Functional Cloning 
. of ICAM-2, a CeU Adhesion I&and for LFA-1 Homologous 
to ICAM-1. Nature 1989, 339:61-64. 
Functional cloning and identiftcation of ICAM-2, a second Ugand 
for IFA-1. Although this integral membrane-molecule has oniy hvo 
immunogiobulin-like domains they are closely reiated to the two most 
N-terminal domains of the other LFA-1 i&and, ICAM-1. 
We are thankful to Drs AA Brian, EA Clark, NK Damie, B Dupont, 
MK Jenkins, L Kouiova, P Kuhiman, PS Iinsiey, JA Ledbetter, P Moin- 
geon, C Morimoto, W Newman, RJ Noeile, and EL Reinhen for shar- 
ing with us unpublished data and papers prior to publication. The 
critical reading of the manuscript by Drs RE Gress and RJ Hodes is 
highly appreciated. GA van Seventer is a visiting associate supported 
by the Fogarty Exchange Program. Y Shimizu was supported by 
Damon-Runyon Waiter Wiicheii Cancer Research Fund Postdoctoral 
Fellowship DRG-993. 
11. A~~ANN DM, Hocc N, TROWSDALE J, WIUUN~QN D: Cotram- 
. fection of RAM-1 and HLA-DR Reconstitutes Human Anti- 
gen Presenting CeU Function in Mouse L Cells. Nature 1989, 
338~512-514. 
Reports that through transfection experiments, co-expression of 
ICAMl with HIA-DR on mouse Iibrobiasts is criticai for effective HIA 
class-U-restricted and silo-specific human T-cell activation. 
12. Sru G, HEDRICK SM, BRIAN AA: Isolation of the Murine Inter- 
. cellular Adhesion Molecule 1 (ICAM-1) Gene. RAM-1 en- 
hances Antigen-specific T CeU Activation. J Immunoll989, 
14338133820. 
References and recommended reading 
Isolation and characterization of murine ICAMl indicates that it has 
limited homology with human ICAMl. Transfection of murine ICAMl 
augments APC function of MHC class-II fibrobiasts. 
Papers of special interest, published within the annual period of review, 
have been highlighted as: 
. of interest 
. . of outstanding interest 
1. ClEvEa.s H, hARCON B, WILEMAN T, TERHORST C: The T 
Cell Receptor/CD3 Complex: A Dynamic Protein Ensem- 
ble. Annu Rev Immunol 1988, 6:629&Z. 
13. VAN SEVENTER GA, SH~M~ZU Y, HORGAN KJ, SHAW S: The LFA-1 
. Ligsnd ICAM- Provides an Important Costimulatoty Signal 
for T CeU Receptor-mediated Activation of Resting T CeUs. 
J Immund l!BO, 144:457945f36. 
Reports that atUnity-puriIied ICAMl provides co-stimulation in a CD3 
mAi.-mediated proliferation model. 
2. SCHWARTZ RI-I: A CeU Culture Model for T Lymphocyte 
CIonaI Anergy. Science 1990, 248:1349_1355. 
14. KUHLMAN P, MOY VT, Low BA, BIUAN AA: The Accessory 
. Function of Murine ICAM- in T Lymphocyte Activation: 
Contributions of Adhesion and Co-activation. J Immund 
1991, 146317731782. 
3. Cm EA, IEDBETTER JA Amplification of the Immune 
Response by Agonist& Antibodies. Immunol Today 1986, 
7:267-270. 
Murine ICAMl can function as a Ugand for mLFA-1 in adhesion assays. 
Furthemrore mICAM1 enhances antigen-specific T-cell activation by af 
fecting the dose-dependence of the response. 
4. GEPPERT TD, Dews IS, GUR H, WACHOLTZ MC, L~KY PE: Ac- 
cessory Cell Signals InvoIved In T-cell Activation. Immunol 
Rev 1990, 117:1-&. 
15. PARDI R, BENDER JR, DETTORI C, G~NNAZZA E, ENGLEMAN 
. EG: Heterogeneous Disttibution and Trsnsmembrsne Si& 
naU.ng Properties of Lymphocyte Function-sssocisted Anti- 
gen @A-l) in Human Lymphocyte Subsets. J Immund 
1989, 1433157-3166. 
5. SHAW S, SHIM~ZU Y: Two Molecular pathways of Human T 
Cdl Adhesion: Establishment of Receptor-I&and ReIation- 
ship. Curr @in Immund 1988, 1:92-97. 
Documents sIgna&ng through LFA-1. LFA-1 crossIinking on peripheral 
T cells resuits In phosphoinositide hydrolysis and a rise in [Caa+], 
when using CDlla (LFA-1 u-chain) but not anti-CD18 (LFA-1 U-chain) 
InAbS. 
6. MOINGEON P, CHANG H, WAUNER BP, STEBBINS C, FREY AZ, 16. WACHOLTZ MC, PATEL SS, DUSKY PE: Leukocyte FunctIon- 
. REINHERZ EL CDZ-medisted Adhesion Fscilitates T Lympho- . assockated Ant&en 1 is an Activation Molecule for Human 
cyte Recognition Function. Nature 1989, 339~312-314. T CeIIs. J .G$J Med 1989, 170:431--448 
Documents that by transfection of CD2 cDNA constructs iacking the 
cytoplasmic signal transduction element, adhesion of CD2 with LFA-3 
aione can account for its faciitating effect on antigen-specific T-cell re- 
SponseS. 
Neither CDlla nor CD18 mAbs alone, induced a rise in [Caz+], in 
T-cell clones, but combined with crosslInked CD3 mAbs a more pro- 
longed calcium signal was observed than that observed when CD3 
alone was ctossiinked. The IL-2 production and DNA synthesis were 
Roles of multiple accessory molecules in T-cell activation van Seventer, Shimizu, Shaw 301 
~ greati enhanced under these conditions of crosslinking both CD3 
and LFA-1. 
17. JUNE CH, IXDBETIZR JA, J.INSIIX PS, THOMPSON CB: Role of 
the CD28 Receptor in T-cell Activation. Immund Today 
1990, 11:211-216. 
IFI mstxy PS, Clwc EA, LEDB~R JA: T-cell Antigen CD28 Me- __t 
. . &es Ad&&on with B Cells by Interacting &th Activation 
Ant&en B7/BB-1. f’roc Nat1 Acad Sci USA 1990,87:5031-5035. ---- 
Cloning and identification of the B-cell activation antigen B7/BB-1 as 
a @md for CD28 B7/BB-1 is an immunoglobulin-supergene famUy 
-her, which when transfected into COS cells, mediates adhesion to 
CD28_transfected Chinese hamster ovary cells in a divalent cation-inde- 
+t manner. This report provides the Important and long-awaited 
ident&ation of the natural ligand of CD28 
19. I_~~~SIN PS, BRADY W, GROS~WRE L, ARUFFO A, DAMIE NK, 
. UDBEITER J: BindIng of the B Cell Activation Antigen B7 
to CD28 Cc&imulates T CeU ProUferatIon and IL-2 mRNA 
Accumulation. J EjsD Med 1991, 173~721-730. 
Reports that CD28 binds to B7/BB-1 in the absence of other gccessory 
molecules, and that Interaction between CD28 and B7/BB-1 is co-stim- 
htory for T-cell activation, resulting in proliferation and increased IL-2 
transcription. 
20. IXDBETIER JA, IMBODEN JB, SCHIEVEN GL, GROSMAIRE IS, 
. EABINOVITCH PS, -TEN T, THOMPSON CB, JUNE CH: CD28 
Ligation in T-cell Activation Evidence for l’wo Sii Trans- 
duction Pathways. E[ood 1990, 75:1531-1539. 
Studies that exploit PMAmedlated inhibition indicate CD28 aggregation 
mediates its effect on inositol phosphate and stimulates [Caz+] rise 
through a phospholipase C activation pathway that is distinct from the 
TCR-CD3-linked pathway. 
21. F~USER JD, ~RVSNG BA, CIUBTREE GR, WEL% A: Regulation of 
. Interleukin-2 Gene Enhancer Activity by the T CeU Acces- 
sory Molecules CD28. Science 1991, 251:313-316. 
Stimulation of CD28 induces the formation of a protein complex that 
binds to a regulatory region of the IL2 gene that is distinct from pre- 
viously described regions. 
22. LINDSIXIN T, JUNE CH, LEDBE~R JA, STEUA G, THOMPSON 
. CB: Regulation of Lymphokine Messenger RNA Stability by 
a Surface-mediated T Cell Activation Pathway. Science 1989, 
244~339-343. 
The CD28 activation pathway in T cells specifically regulates the stability 
of mRNAs for the lymphokines IL-2, INF-y, TNF-a and GM-CSF. 
23. SHIMIZU Y, SHAW S: Lymphocyte Interactions with Extracel- 
Iuku Matrix. FASEB J 1991, in press. 
24. WAYNER EA, GARCL~-PARDO A, HUMPHRIES MJ, MCDONIUD JA, 
. CAI?I%R WG: Identification and Characterization of tbe T 
Lymphocyte Adbesion Receptor for an Alternative CeII At- 
tachment Domain (CSl) in Plasma Fibfonectin. J CeN Bid 
1989, 109:1321-1330. 
Identification of a new site of recognition for T cells, CS-1, that is on 
FN and is distinct from the ArgGlyAsp-peptide sequence. 
25. SHIMLZU Y, VAN SEVENIXZR GA, HORGAI~ KJ, SHAW S: Regulated 
. Expression and Function of Three VLA (beta-l) Integrin 
Receptors on T Cells. Nature 1990, 3453250-253. 
Confirms and further investigates the concept of TCR-induced regu 
lation of k&grin function by demonstrating rapid induction of T-cell 
binding through VIA-4 and VIA-5 to fibronectin, and through ~-6 to 
W upon T-cell activation. 
26. DANG NH, TORIMO’IO Y, SC-MAN SF, MORIMOTO C: Human 
. CD4 Helper T CeU Activation: Functional Invobement of 
Two Distinct Collaften Recet%vrs, lF7 and VLA Integrin 
Family. J Eg Med I?90, 172:&4%52. 
T-cell CD26 (DPP IV) and VIA-~ both bind to Cohen and both oro- 
tide co-stimulation & a CD3 m&-mediated proUfe&on system. 
27. NOJIMA Y, HUMPHRIES MJ, MOULCJ AP, KOMORNA k YAMADA 
. KM, SCHLOSSMAN SF, MOIUMOTO C: VW-4 Mediates CD, 
dependent CD4+ T CeU Activation Via tbe CSl Alter- 
natively Spliced Domain of FIIronectln. J Ihp Med 1990, 
172:118ct1192. 
T cell VIA-4 provides co-stimulation by biding to the CS-1 region of 
FN in a CD3 mAb-mediated proliferation model. 
28. MATXIYAMA T, YAMADA A, KAY J, YAMADA KM, AKIyMlA SK, 
. SCHX%SMAN SF, Mo~OTO C: Activation of CD4 Cells by Fi- 
bronectin and anti-CD3 Antibody. A Synergistic Effect Me- 
diated by the Vu-5 FIbronectIn Receptor Complex. J Lhp 
Med 1989, 170:11331148. 
T cell VL4-5 provides co-stimulation by bmding to an Arg-Gly-Asp-pep- 
tide sequence on PN in a CD3 mAbmedia@d proliferation model. 
29. SHIMIZU Y, VAN &VENTER GA, HORGAN KJ, SHAW S: Costimu- 
. lation of proliferative Responses of Resting CD4+ T CeUs 
by the Interaction of VLA-4 and VLA-5 with FIbronectIn 
or VLA-6 with LamInin. J Immund 1990, 145:5%7. 
Resting CD4+ T cells arr co-stimulated by Interaction of FN with T ceU 
VIA-4 or vu\-5, and of LN with T ceil VIA-6 in a CD3 mAbmediated 
proliferation model. 
30. DAMS IS, OPPENHEIMER-MARKS N, BEDNARIXK JL, McIMyRE 
. BW, LlpsKy PE: Fibronectin Promotes Proliferation of Naive 
and Memory T Cells by SignaUing Through Both VLA-4 and 
VLA-5 Integrin Molecules. J Immund 1990. 145:78+793. 
FN augments CD3 mAb-mediated proliferation of both the naive and 
memory subsets of T cells by binding to T-cell MA-4 and m-5. 
31. EUCES MJ, OSBORN L, TAKADA Y, CROUSE C, Lu~owsw~ S, 
. HEMLER hlE, COBB RR: VCAM-1 on Activated Endothelium 
Interacts with the Leukocyte IntegrIn VLA-4 at a Site DIs- 
tinct from the VIA4/FIbronectIn Binding Site. Ceu 1990, 
60:5n-584. 
Documents that specilic interaction of VL4-4, transfected in K562 cells, 
with VCAM-1 occurs through a site that is different from that through 
which the interaction of VIA-4 with FN occurs. 
32. YAMADA , Nm T, NOJIMA Y, SCHLO?&MAN SF, MORIMOTO 
. C: Activation of Human CD4 T Lymphocytes. Interaction 
of FIbronectIn with VLA-5 Receptor on CD4 Cells Induces 
the AP-1 Transcription Factor. J Immund 1991, 146:5356. 
T-cell VIA5 binding to immobilized FN activates the IL-2 transcription 
factor AP-I. 
33. DUSTIN ML, SPRINGER TA T-cell Receptor Cross-Unking Tran- 
. . sientIy Stimulates Adhesiveness Through LFA-1. Nature 
1989, 3413619624. 
Reports that TCR-CD3 complex crosslinking increases the avidity of 
LFA-1 for its l&and, ICAM1. This increase in avidity is rapid, transient, 
and not caused by enhanced receptor expression. The induced change 
of WA-1 that results in a high avidity binding state is mediated by intm- 
cellular signals from the TCR-CD3 complex. This detailed description 
of an activation-dependent adhesion pathway has major consequences 
for models of T-cell interaction with apposing cells. 
34. O’ROURKE AM, ROGERS J, MEXHER MF: Activated CD8 Binding 
. to class I Protein Mediated by the T-cell Receptor Results 
in Sigm&ng. Nature 1990, 346:187-189. 
Reports that CD8 binding to class I MHC can provide co-stimulation 
under conditions of low levels of TCR occupancy. 
35. MOUUGEON PE, LUCICH JL, STEBBINS CC, RECNV MA, WALLNER 
. BP, Ko~Asu S, REINHEIZZ EL: Complementary Roles for CD2 
and LFA-1 Adhesion Pathways During T Cell Activation. Eur 
J Immund 1991, 21&X-610. 
In contrast to the rapid Increase of adhesion function of LFA-1, the CD2 
avidity for LFA-3 is already optimal in resting T cells and is not mod&d 
within the first 12 h following TCR-CD3 complex-mediated activation. 
36. DETMJ!RS PA, WRIGHT SD, OLSEN E, KlMBML B, COHN ZA: Ag- 
gregation of Complement Receptors on Human Neutrophils 
in the Absence of Ligand. J Ceu Bid 1987, 105:1137-1145. 
37. VAN KOOYK Y, VAN DE WIEL-VAN KEMENADE P, WEDER P, 
. KIJIJ~ERS TW, FIGDOR CG: Enhancement of LFA-l-mediated 
Cell Adhesion by Triggering Tbrougb CD2 or CD3 on T 
Lymphocytes. Nature 1989, 342:811-813. 
302 Lymphocyte activation and effector functions 
T-cell activation through a pair of CD2 mAbs induces a more prolonged Reports studies of regulation of the endothelial ceU expression of MHC 
induction of high avidity LFA-1 molecules than does crosslinked CD3 class LI, ICAM-I, VCAM-1 and EIAM-1 by IL-4 alone, or in combination 
tllAbS. with TNF, IL-1 or INF-y. 
38. SHIMELI Y, VAN SEVENTER GA, HORGAN KJ, SHAW S: Roles of 
Adhesion Molecules in T Cell Recognition: Fundamental 
Similarities Between Four Integrins on Resting Human T 
Cells @A-l, VLA-4, VLA-5, VLA-6) in Expression, Binding, 
and &stimulation. lmmunol Reu 1990, 114:10!%143. 
49. WEBB DS, SHIMUU Y, VAN SEVENTER GA, SHAW S, GERRAIZD 
. . TL: LFA-3, CD&& and CD45: Physiologic Triggers of 
Human Monocyte TNF and IL-1 Release. Science 1990, 
249:1295-1297. 
39. MOURAD W, GEHA RS, CHA’IU T: Engagement of Major Iiis- 
. tocompatibility Complex Class II Molecules Induces Sus- 
tained, Lymphoctye Function-associated Molecule l-depen- 
dent CeR Adhesion. J E@ &fed 1990, 172:1513-1516. 
Crosslinking of HIA class Il molecules with certain specific mAbs in- 
duces the LFA-1 molecules on monocytes to acquire a high avidity for 
ICAM-1. 
Immobilized mAbs against LFA-3, CD44 and CD45 induce resting mono- 
cytes to r&ase TNF and IL-l. Documents a direct demonstration of 
CD2-LFA-3 induced IL-1 secretion by monocytes with plastic-immo- 
bilized al&&y-purified CD2. This finding provides evidence that T 
cell-monocyte interaction is a bilateral activation event. 
40. SANDEI~S ME, MAKGOBA MW, SHAW S: Human Naive and 
Memory T Cells: Reinterpretation of Helper-inducer 
and Suppressor-inducer Subsets. Immund To&y 1988, 
9:19>199. 
50. IANDIS RC, FRIEDMAN ML, FISHER I, Em TM: Induction of Hu- 
. man Monocyte IL-1 mRNA and Secretion During Anti-CD3 
Mitogenesis Requires Two Distinct T-cell-derived Signals. J 
Immund 1991, 146:128-135. 
41. MORIMOTO C, TORIM~TO Y, IE~IN~ON G, RLIDD CE, SCHKJEBER 
. M, DANG NH, LETVN NL, !~CHLOSSMAN SF: lF7, a Novel Cell 
Surfice Molecule, Involved in Helper Function of CD4 
Cells. J Immunol 1989, 143:343&3439. 
A new mAb lF7 (specilic for an epitope on CD26) inhibits various T- 
cell dependent activation models in vitro It recognizes preferentially 
the memory T-cell subset. 
A study that indicates a two-step model of monocyte IL-1 production. 
The initial signal leads to induction of IL-l mRNA and is mediated by 
direct contact of the monocyte with CD3 mAb-activated T-cells, and a 
subsequent signal is provided by soluble T-cell factors that result in IL-1 
secretion. 
42. MACKAY CR, MARSTON WI+ DUDLER L: Naive and Memory T 
. CeRs Show Distinct Pathways of Lymphocyte Recirculation. 
J E.xp Med 1990, 171:80-817. 
Reports that the expression of cell-surface markers that distinguish hu- 
man naive and memory T-cell subsets is vety similar in sheep. In viva 
recirculation experiments indicate that in sheep most cells in the atTer- 
ent lymph arc of the memory phenotype, whereas a great majority of 
the cells in the efferent lymph are of the naive phenotype. 
51. KAWAKAMI K, YAMAMOTO Y, KAKLMOTO K, ONOUE K: Require- 
. . ment for Delivery of Signals by Physical Interaction and 
Soluble Factors from Accessory Cells in the Induction of 
Receptor-mediated T-cell Proliferation. E@ectiveness of IFN 
gamma Modulation of Accessory CelIs for Physical Interac- 
tion with T Cells. J Immunol 1989, 142:1818-1825. 
Reports three requirements for monocyte-dependent CD3 mAbmedi 
ated activation of resting T cells: TCR-CD3 crosslinking; soluble me- 
diators from activated monocytes, such as IL-l and IL-~; and ceU_ceU 
contact with fixed IFN-y activated monocytes. Fixed resting monocytes 
are incapable of providing this accessory signal. This demonstrates el- 
egantly the importance of ceU_ceU contact in T-cell co-stimulation by 
monocytes. 
43. BEV~IACQUA MP, STENGEUN S, G~~BRONE MA JR, SEED B: En- 
. dothelial Leukocyte Adhesion Molecule 1: an Inducible Re- 
ceptor for Neutrophils ReIated to Complement Regulatory 
Proteins and Lectins. Science 1989, 243:11@--1164. 
Cloning and characterization of the cytokine-inducible EL4M1, an LN- 
adhesion molecule for neutrophil binding to endothelial ceils. 
52. KOULOVA I, Cm EA, SHU G, DUPONT B: The CD28 Ligand 
. B7/BBl Provides Costimulatory Signal for Alloactivation of 
CD4+ T Cells. J Eq Med 1991, 173:75%762. 
This study shows that CD28 and B7/BB-1 n-&s inhibit aUo-activation 
of CD4+ T cells by B Iymphoblasts. It also demonstrates that crosslink 
ing of HLA-DR antigens on resting B cells induces rapid expression of 
B7/BB-1. 
44. SHU&ZU Y, SHAW S, GRABER N, GOPAL TV, HORGAN KJ, 
. VAN SEVENTER GA, NEWMAN W: Activation-independent Bind- 
ing of Human Memory T Cells to ELAM-I. Nature 1991, 
349:7-2. 
Reports that the memory subset of CD4+ T cells exclusively bind to 
put&d EL4M-1. This T-cell binding to Em-1 occurs independently 
of T-ceU activation. 
45. PICKER LJ, K~IMOTO TK, SMITH CW, WARN~~K RA, BUTCHER 
. EC: ELAM-1 is an Adhesion Molecule for Skin-homing T 
Cells. Nature 1991, 349~796-799. 
53. BARTI+?T WC, MICHAEL A, MCCANN J, YUAN D, CLUSEN E, 
. . NOELLE RJ: Cognate Interactions Between T Cells and B 
Cells. IL Dissection of Cognate Help by using a class II- 
restricted, Antigen-specitk, IL-2dependent Helper T Cell 
Clone. J Immund 1989, 143:1745-1754. 
Dissection of murine T-cell help for B cells into two phases, an early 
cell contact-dependent event that induces B-ceU cycle progression into 
Gl (IL-2 independent) and an IL-2 dependent T-cell production of lym 
phokines that mediates subsequent B-cell prolifemtion. 
A unique skin-associated subset of memory T cells defined by the ex- 
pression of the cutaneous lymphocyte-associated antigen (HECA 452) 
binds to Em-1 transfectants. 
46. Dus?w ML, SPRINGER TA: Lymphocyte Function Associated 
Antigen-l (LFA-1) Interaction with Intracellular Adhesion 
Molecule -1 (ICAM-1) is One of at Least Three Mechanisms 
for T Lymphocyte Adhesion to Cultured Endothelial Ceils. 
J Cell Bid 1988, 107~321331. 
54. 
. . 
NOELLE RJ, MCCANN , MARSHAIL I, BARTLEIT WC: Cognate In- 
teractions Between Helper T Cells and B Cells. III. Contact- 
dependent, Lymphokine-independent Induction of B CeU 
Cycle Entry by Activated Helper T CeUs. J Immunol 1989, 
143:1807-1814. 
47. &BoRN L, k&SION c, Ruw, ft, v‘4.SW.O c, UJHOWSKYJ S, 
. CHI-ROSSO G, LOBB R Direct Expression CIonIng of Vascular 
Cell Adhesion Molecule 1, a Cytokine-induced EndotheliaI 
Protein that Binds to Lymphocytes. Cell 1989, 59:1203-1211. 
Cloning and characterization of an immunoglobulin-like adhesion 
molecule VCAM-1, which is induced by IL-1 and TNF-u on human en- 
dothelial cells, and binds lymphocytes. 
CeU-ceU contact of a CD3 mAb-activzted murine Th clone with resting 
B cells is required to induce mRNA synthesis in the B ceU (GO to Gl 
in the ceU cycle). Subsequent cytokine production by the activated Th 
clone induces progression of the B ceU to the S phase. IL4 is one of 
the cytokines required for this process. 
55. Bmrr WC, MCCANN J, SHEPHERD M, ROY M, NOELLE RJ: 
. Cognate Interactions Between Helper T CeRs and B Cells. 
N. Requirements for the Expression of mector Phase Ac- 
tivity by Helper T CeRs. J Immunoll990, 145:3956-3%2. 
48. THORNHIU MI-I, HASKARD O: IL-4 Regulates EndotheIiaI Cell 
. Acthation by IL-l, Tumor Necrosis Factor, or IFN-gamma. 
J Immund 1990, 145:865-872. 
This Study teports that ody plasma membranes from acthated murine 
T-cell clones (both Thl-type and Th2-type) provide a cell-cd contact- 
mediated signal that in combination with IL-4, Induces B-ceU prolifera- 
tion. This activation-induced, membrane-bound signal is dependent on 
de norm synthesis of protein. 
Roles of multiple accessory molecules in T-cell activation van Seventer, Shimizu, Shaw 303 
56. HONKIN PD, YAMASH~TA LC, COFFMAN & KEHR( MR: SqWd 
. don of Events Meckting B CeU ProIiferation and Ig Pro- 
dudon by Using T CcU Membranes and Lymphokines. J 
~mmun& 1990, 145:2025-2034. 
Documen~ that membranes from activated Th cells In combination 
drh u-4 and IL-5, induce BceU proliferation and diikrentiation. An 
.&~tion.induced, dtz nova synthesized, membrane-bound signal on 
e ceUs Is involved in cell contact between T-cell membranes and B 
c&s. 
57. IQIEGER JI, GRAMMER SF, GREY HM, CHEST RW: Antigen Pre- 
sentation by Spknic B Cells: Resting B Cells are Ineffective, 
Whereas ActivaWd B Cells are Etfective Accessory CeUs for 
T CeU Responses. J Immunol 1985, 135:2937-2945. 
58. JENKN MK, BLJRREU E, ASHWELL JD: Antigen Presentation by 
. Resting B Cells: Etkctiveness at Inducing T Cell prolifer- 
ation is Detexmined by Costimulatory Signals, not T Cell 
Reckptor Occupancy. J Immund 1930, 144:1585-1590. 
LOW density and resrIng B cells express similar levels of Antigen-mC 
class II, but only low density (highly enriched for activated) B cells pro- 
vide the co-stimuiatoty signals required for IL-2 production. 
59. DAM~E NK, LINSLEY P’S, IEDBETER JA: Direct Helper T CelI- 
. induced B-cell Werentiation Involves Interaction Between 
T-cell Antigen CD28 and B-cell Activation Antigen B7. Eur 
/ Immund 1991, In press. 
MAb blocking studies demonstrate that the CD28-B7 pathway is 
Involved In T-cell-induced difFerenriation of atlo-antigen-presenting 
B &Is inro Immunoglobulin-secreting cells. 
60. TOHMA S, HIROHATA S, LIPSKY PE: The Role of CDlla/CD18- 
. CD54 Interactions in Human T Celldependent B CeU Ac- 
tIvation. J Immunol 1991, 146:492-499. 
Documents that LPA-l-IcAM- is involved in T-cell-dependent B-cell ac- 
tivation. Using LPA-1 deficient T cells, the authors establish a role for 
LFA-1 on the B cell, and ICAM- on the T cell. 
61. EMIL D, WALIGN C, GALWAUD P, FISCHER A, OWE D, 
DEWWSSY JF: Role of the LFA$CDZ Interaction in Hu- 
man SpeciEc B Cell Differentiation. / Immund 1988, 
141:1912-1918. 
62. CERDAN C, m Y, BRAILY H, COLKOC; ?A, FL*.?z‘TT~ $ 
. CO~TEUU R, MAWAS C. BIRG F, 0~ L), IL-lalpha is Pro 
duced by T Lymphocytes Activated via the CD? .V!r?i 8 r17s 
Pathways. J lmmunol 1991, 146:56@-564. 
Iate IL-la secretion by T cells is mediated oniy through a combination 
of CD2 and CD28 mAbs. These m&s however, are each able, to inducz 
T-cell proliferation and TiVFo! secretion. 
63. ELJAAFARI A, VAQLJERO C, TEILLWD JL, BISMUTH G, HWRO? C. 
. DORVM I, BERNARD A, STERKERS G: Helper or CytoIytic Func- 
tions can be Selectively Induced in Bifunctional T Cell 
Clones. J fi.q Med 1990, 172:213218. 
Two distinct pairs of CD2 m&s, which induce different second mes 
sengers, stimulate CD4 T-cell clones to elicit either helper or qtolytic 
functions. The helper function is associated with a rise in [Caz + 1, and 
phospholipase C activation, whereas the cytolytic function is induced 
in the absence of detectable levels of these second messengers. 
GA van &venter and S Shaw, Experimental Immunology Branch, Na- 
tional Cancer Institute, National Institutes of Health, Bethesda, Matyiand 
20892, USA 
Y Shim& Department of Microbiology and Immunology, University of 
Michigan Medical School, AM Arbor, Michigan 48109, USA, 
